The Federal Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have recommended that the administration of the Johnson & Johnson single-dose vaccines be temporarily stopped.
This provision will be implemented immediately as a extreme precautionary measure after they presented some rare cases of blood clots, in six women who received the inoculation.
The use of these particular doses will be stopped in several federal vaccination centers and, for the time being, in state campuses.
In this regard, the commissioner of the state Department of Health, Howard Zucker, pointed out that for today, all existing appointments to get the J&J vaccine will be made but the drug applied will be that of Pfizer.
And he recommended: “Those who have received the J&J vaccine and who experience severe headaches, abdomen and legs, or are short of breath, within three weeks after being vaccinated, should contact their healthcare provider.” .
Nearly 7 million doses of Johnson & Johnson have been applied in the United States so far.
This order does not affect Pfizer or Moderna vaccines.
Visit the NY1 News page with our special coverage on the coronavirus: Coronavirus outbreak
á é í ó ú ñ
– .
